Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Pomalidomide plus low-dose dexamethasone versus high-dose... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial
0
Authors
Jesús Miguel
•
Katja Weisel
28 more
•
Meletios Dimopoulos
Published
September 3, 2013
Paper
Conversation
0
Reviews
0
Bounties
0
Abstract
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Cancer Oncology
Internal Medicine
Hematology
Gastroenterology
Physics
Cancer Oncology
Medicine
Internal Medicine
Hematology
Show all topics
DOI
10.1016/s1470-2045(13)70380-2
